NIO
NIO Inc.
NIO has the edge over PHM overall, supported by stronger fundamentals and stronger valuation.
PHM
PulteGroup, Inc.
PHM trails on the overall score without a compensating advantage in the available component scores.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
PHM Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Stable | |
| Strong |
PHM's balance sheet is currently strong, and its profitability and cash flow are stable, but its revenue is under pressure.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
PHM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.8x | $54.71 | -57% |
| Fair | 8.8x | $82.04 | -35% |
| Expensive | 11x | $99.83 | -21% |
| Current | 14x | $127 | — |
| Forward | 14x | $127 | — |
Historical ranges are pointers, not guarantees.
PHM's PE is in its expensive range at 13.6x. On analysts' estimates for next year's earnings, today's price would be 13.7x.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
NIO has the edge over PHM on the outlook, with more favorable earnings and revenue expectations.
PHM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect PHM's profitability to weaken, with its earnings and revenue holding steady. However, they disagree widely on these estimates.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
PHM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.29 | -0.7% |
| Q3 2026 | $9.36 | -28% |
| Q2 2026 | $9.79 | -27% |
| Q1 2026 | $10.34 | -27% |
| Q4 2025 | $11.12 | -24% |
| Q3 2025 | $12.97 | -4.2% |
| Q2 2025 | $13.36 | +2.1% |
| Q1 2025 | $14.16 | +14% |
| Q4 2024 | $14.69 | +25% |
PHM has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over PHM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
PHM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4B | -9.8% |
| Q2 2026 | $4B | -9.6% |
| Q1 2026 | $3.4B | -12% |
| Q4 2025 | $4.6B | -6.3% |
| Q3 2025 | $4.4B | -1.6% |
| Q2 2025 | $4.4B | -4.3% |
| Q1 2025 | $3.9B | -1.4% |
| Q4 2024 | $4.9B | +15% |
PHM's revenue has slid since its 2022 peak: $4B last quarter, down 9.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | -1.7 points |
| Q2 2026 | 16% | -2.7 points |
| Q1 2026 | 13% | -4.3 points |
| Q4 2025 | 14% | -9.8 points |
| Q3 2025 | 17% | -2.8 points |
| Q2 2025 | 18% | -4.5 points |
| Q1 2025 | 18% | -4.5 points |
| Q4 2024 | 24% | +2 points |
PHM has the edge over NIO on profitability, with a higher operating margin.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
PHM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $437.2M | -33% |
| Q2 2026 | -$12.9M | -105% |
| Q1 2026 | $134.4M | +28% |
| Q4 2025 | $739.8M | +36% |
| Q3 2025 | $651.1M | +56% |
| Q2 2025 | $253M | -35% |
| Q1 2025 | $104.6M | -51% |
| Q4 2024 | $543.1M | +106% |
PHM still generates free cash flow, though less than at its 2022 peak: $1.3B over the past year.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PHM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.6x | Net Cash |
| Q3 2025 | 0.0x | Very low |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | -0.4x | Net Cash |
PHM's net debt is less than a year of its operating earnings (EBITDA).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
PHM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.2 | Neutral |
| Stochastic | 66.1 | Neutral |
PHM's weekly RSI is 53 (neutral) and its Stochastic is 66 (neutral).
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
PHM PE vs Consumer Cyclical Sector
| Metric | PHM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 18x | 25% below |
| PE % | 99 | 47 | 52 pts above |
PHM is trading at 14x earnings, a 25% discount to the Consumer Cyclical sector's median of 18x.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
PHM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $120.8 | 5% above |
| 20 week MA | $124.3 | 2.1% above |
| 50 week MA | $124.4 | 2% above |
| 100 week MA | $118.8 | 6.8% above |
| 200 week MA | $107.7 | 18% above |
PHM has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.
PHM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $38.8 | $45.2 | +17% |
| 2021 | $45.2 | $54.7 | +21% |
| 2022 | $54.7 | $45.8 | -16% |
| 2023 | $45.8 | $103.2 | +125% |
| 2024 | $103.2 | $109.5 | +6.1% |
| 2025 | $109.5 | $119.2 | +8.8% |
| 2026 YTD | $119.2 | $126.9 | +6.5% |
PHM has the edge over NIO on returns for 2026, with the stronger performance.